Aspen Dangles £700M Bid For GSK Drugs
GlaxoSmithKline PLC on Wednesday disclosed that Aspen Pharmacare Holdings Ltd. has offered £700 million ($1.1 billion) to purchase two of the pharmaceutical giant's thrombosis drug brands and a manufacturing facility in...To view the full article, register now.
Already a subscriber? Click here to view full article